|
BMRN | Biomarin Pharmaceutical Inc |
|
|
BMRN | Biomarin Pharmaceutical Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.58 |
| Leverage | 20.46% |
| Market Cap | $ 10.4B |
| PE | 19.95 |
| Dividend Yield | 0.00% |
| Profit | $ 520.5m |
| Margin | 16.87% |
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.